Long-Term Efficacy and Safety of Adjunctive Perampanel in Elderly Patients with Focal-Onset Seizures by Concomitant Anti-Seizure Medication (ASM) Use

被引:0
|
作者
Marawar, Rohit [1 ]
Leppik, Ilo E. [2 ]
Wechsler, Robert T. [3 ]
Patten, Anna [4 ]
Ngo, Leock Y. [5 ]
Malhotra, Manoj
机构
[1] Wayne State Univ, Detroit, MI USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] Idaho Comprehens Epilepsy Ctr, Boise, ID USA
[4] Eisai Europe Ltd, Hatfield, Herts, England
[5] Eisai Inc, Woodcliff Lake, NJ USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
230
引用
收藏
页码:53 / 54
页数:2
相关论文
共 50 条
  • [1] Long-Term Efficacy and Safety of Adjunctive Perampanel in Elderly Patients (Aged ≥60 Years) with Focal-Onset Seizures (FOS): Post Hoc Analysis of Open-Label Extension (OLEx) Studies by Enzyme-Inducing Anti-Seizure Medication (EIASM) Use
    Marawar, Rohit
    Leppik, Ilo E.
    Wechsler, Robert T.
    Patten, Anna
    Ngo, Leock Y.
    Malhotra, Manoj
    [J]. ANNALS OF NEUROLOGY, 2021, 90 : S110 - S111
  • [2] Adjunctive Perampanel and Levetiracetam in Patients with Focal-Onset Seizures Co-administered With/Without Enzyme-Inducing Anti-Seizure Medications
    Goldman, Samantha
    Ngo, Leock Y.
    Patten, Anna
    Malhotra, Manoj
    [J]. EPILEPSIA, 2021, 62 : 58 - 58
  • [3] Long-term Seizure Freedom with Adjunctive Perampanel in Patients Aged 4-<12 Years with Focal-onset Seizures or Generalized Tonic-clonic Seizures
    Ngo, Leock Y.
    Flamini, Robert
    Patten, Anna
    Malhotra, Manoj
    [J]. PEDIATRICS, 2022, 149 (01)
  • [4] The efficacy and safety of adjunctive perampanel for the treatment of refractory focal-onset seizures in patients with epilepsy: A meta-analysis
    Li, Yiming
    Zeng, Ya
    Mu, Jie
    Zhou, Dong
    [J]. EPILEPSIA OPEN, 2022, 7 (02) : 271 - 279
  • [5] Long-term seizure freedom with adjunctive perampanel in patients aged 4-&lt;12 years with focal-onset seizures or generalised tonic-clonic seizures
    Flamini, Robert
    Patten, Anna
    Malhotra, Manoj
    Ngo, Leock Y.
    [J]. EPILEPSIA, 2021, 62 : 268 - 269
  • [6] ELEVATE Study 410 of perampanel as monotherapy or first adjunctive therapy in patients with focal-onset seizures or generalised tonic-clonic seizures: Analysis by first-line enzyme-inducing anti-seizure medication use
    Klein, P.
    Samad, O.
    Kumar, D.
    Ngo, L. Y.
    Malhotra, M.
    [J]. EPILEPSIA, 2022, 63 : 139 - 139
  • [7] Efficacy and Tolerability of Perampanel as Adjunctive Therapy in Chinese Patients With Focal-Onset Seizures: An Observational, Prospective Study
    Zhang, Ranran
    Qiao, Shan
    Fang, Xiqin
    Wang, Kemo
    Shi, Yanting
    Du, Qianwen
    Yang, Tingting
    Liu, Xuewu
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [8] Long-term efficacy and safety of adjunctive perampanel in patients from the Asia-Pacific region with refractory focal-onset seizures in Study 335 open-label extension
    Nishida, Takuji
    Lee, Sang Kun
    Inoue, Yushi
    Saeki, Kazunori
    Ishikawa, Kohei
    Malhotra, Manoj
    Patten, Anna
    Kaneko, Sunao
    [J]. EPILEPSIA OPEN, 2024, 9 (02) : 501 - 512
  • [9] FAME study: Efficacy and safety of perampanel as first adjunctive therapy after first or second monotherapy in patients with focal-onset seizures
    Kim, Ji Hyun
    Kim, Dong Wook
    Dash, Amitabh
    Lee, JiWoong
    Malhotra, Manoj
    [J]. EPILEPSIA, 2021, 62 : 43 - 43
  • [10] Long-Term Effects of Concomitant Anti-Seizure Medications (ASMs) During Adjunctive Perampanel Treatment in Paediatric Patients (Aged 4-
    Fogarasi, A.
    Patten, A.
    Ngo, L. Y.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 435 - 436